ABO blood group and COVID‐19: a review on behalf of the ISBT COVID‐19 Working Group
Ruchika Goel(Johns Hopkins University), Dana V. Devine(University of British Columbia), Adaeze Oreh(Federal Ministry of Health), Naomi Rahimi‐Levene(Assaf Harofeh Medical Center), Thachil Jecko(Manchester University NHS Foundation Trust), Satyam Arora(BLK Super Speciality Hospital), Mary Townsend(Vitalant), Cynthia So‐Osman(Erasmus MC), Evan M. Bloch(Johns Hopkins University), Kevin J. Land(Urology San Antonio), France Pirenne(Établissement Français du Sang), Arwa Z. Al‐Riyami(Sultan Qaboos University Hospital), Gopal Kumar Patidar(All India Institute of Medical Sciences), Steven L. Spitalnik(Columbia University), Elizabeth P. Crowe(Johns Hopkins University), Salwa Hindawi(King Abdulaziz University), Erica M. Wood(Monash University), Celina Montemayor(Canadian Blood Services), Karin van den Berg(University of Cape Town), Marion Vermeulen(University of California, San Francisco), Katherine Serrano(University of British Columbia), Hans Vrielink(Sanquin), Cassandra D. Josephson(Emory University), Laetitia Dau(Johns Hopkins University)
Cited by 154
Related Papers
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863
Patient Blood Management
|JAMA|2019|619
A Literature Review of Zika Virus
|Emerging infectious diseases|2016|615
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
|JCI Insight|2020|600
Effects of Red-Cell Storage Duration on Patients Undergoing Cardiac Surgery
|New England Journal of Medicine|2015|486